EUVIMEDOpdag EUVIMED
Übersichtsarbeit

TGF-beta1 WNT and SHH signaling in tumor progression and in fibrotic diseases

Maria D Castellone, Mikko O Laukkanen

Frontiers in Bioscience · 2017 · 9 (1) · 31-45

DOI: 10.2741/s470 ↗

At a glance

Übersichtsarbeit in Frontiers in Bioscience, 2017. Written by Maria D Castellone and 1 co-authors. Institution: IEOS-CNR, Via Pansini 5, 80014 Naples, Italy, and Dipartimento di Medicina Molecolare e Biotecnologie mediche, University of Naples Federico II, Via …. Cited 31 times so far (Crossref).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Activation of resting fibroblasts to myofibroblasts characterizes several physiological and pathological conditions, from wound healing to aggressive metastatic cancers. In tissue damage, including wound healing, fibroblasts are activated in response to injury for a limited period of time to stimulate the healing process. Similar biological mechanisms are maintained in pathological conditions, e.g., scleroderma and cancer, where myofibroblasts persist in producing cytokines and growth factors to drive the development of fibrosis and the progression of disease. Studies characterizing the bi-directional signal transduction pathways between cancer cells and stromal cells have suggested novel druggable targets that may function in both the inhibition of fibrotic reactions in cancer stroma and in the inhibition of fibrotic diseases. In this review, we focus on transforming growth factor beta (TGF-beta), int/Wingless (WNT), and sonic hedgehog (SHH) signal transduction pathways and describe small molecule inhibitors that are used in phase I/II clinical trials to treat fibrosis or fibrotic cancers.

Subjects

MeSH terms (MEDLINE)

AnimalsAntineoplastic AgentsClinical Trials as TopicDisease ProgressionFibrosisHedgehog ProteinsHumansNeoplasmsSignal TransductionSmall Molecule LibrariesTransforming Growth Factor beta1Wnt ProteinsWnt Signaling Pathway

Substances

Antineoplastic AgentsHedgehog ProteinsSmall Molecule LibrariesTransforming Growth Factor beta1Wnt Proteins

Authors and institutions

  • IEOS-CNR, Via Pansini 5, 80014 Naples, Italy, and Dipartimento di Medicina Molecolare e Biotecnologie mediche, University of Naples Federico II, Via Pansini 5, 80014 Naples, Italy.
  • IRCCS SDN, Via E. Gianturco, 801431 Naples, Italy, mlaukkanen@sdn-napoli.it.

Cite

APA

Castellone, M. D., & Laukkanen, M. O. (2017). TGF-beta1 WNT and SHH signaling in tumor progression and in fibrotic diseases. Frontiers in Bioscience, 9(1), 31-45. https://doi.org/10.2741/s470

Vancouver

Castellone MD, Laukkanen MO. TGF-beta1 WNT and SHH signaling in tumor progression and in fibrotic diseases. Frontiers in Bioscience. 2017;9(1):31-45. doi:10.2741/s470

BibTeX
@article{Castellone2017,
  author = {Castellone, Maria D and Laukkanen, Mikko O},
  title = {TGF-beta1 WNT and SHH signaling in tumor progression and in fibrotic diseases},
  journal = {Frontiers in Bioscience},
  year = {2017},
  volume = {9},
  number = {1},
  pages = {31--45},
  doi = {10.2741/s470}
}
Start for free →